Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?
British Journal of Radiology · 28.02.2024 · 97 (1155) · 607-613
DOI: 10.1093/bjr/tqae001 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, online erschienen am 04.01.2024. Verfasst von Yoshifumi Noda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To evaluate the diagnostic performance of CT in the assessment of extra-pancreatic perineural invasion (EPNI) in patients with pancreatic ductal adenocarcinoma (PDAC).
Methods
This retrospective study included 123 patients (66 men; median age, 66 years) with PDAC who underwent radical surgery and pancreatic protocol CT for assessing surgical resectability between September 2011 and March 2019. Among the 123 patients, 97 patients had received neoadjuvant chemoradiation therapy (CRT). Two radiologists reviewed the CT images for evidence of EPNI using a 5-point scale (5 = definitely present, 4 = probably present, 3 = equivocally present, 2 = probably absent, and 1 = definitely absent). Diagnostic performance for assessing EPNI was evaluated with receiver operating characteristic (ROC) curve analysis.
Results
The sensitivity, specificity, and area under the ROC curve for assessing EPNI were 98%, 30%, and 0.62 in all patients; 97%, 22%, and 0.59 in patients with neoadjuvant CRT; and 100%, 100%, and 1.00 in patients without neoadjuvant CRT, respectively. False-positive assessment of EPNI occurred in 23% of patients (n = 28/123), and 100% of these (n = 28/28) had received neoadjuvant CRT. There was moderate to substantial agreement between the readers (ĸ = 0.49–0.62).
Conclusion
Pancreatic protocol CT has better diagnostic performance for determination of EPNI in treatment naïve patients with PDAC and overestimation of EPNI is likely in patients who have received preoperative CRT. Advances in Knowledge Pancreatic protocol CT has better diagnostic performance for the detection of EPNI in treatment naïve patients compared to patients receiving neoadjuvant CRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
- Department of Radiology, Gifu University, Gifu 501-1194, Japan.
- Department of Radiology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
ORCID-Profile: Yoshifumi Noda, Avinash R Kambadakone
Zitieren
APA
Noda, Y., Pisuchpen, N., Parakh, A., Srinivas-Rao, S., Kinowaki, Y., Mino-Kenudson, M., & Kambadakone, A. R. (2024). Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?. British Journal of Radiology, 97(1155), 607-613. https://doi.org/10.1093/bjr/tqae001
Vancouver
Noda Y, Pisuchpen N, Parakh A, Srinivas-Rao S, Kinowaki Y, Mino-Kenudson M, et al. Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?. British Journal of Radiology. 2024;97(1155):607-613. doi:10.1093/bjr/tqae001
BibTeX
@article{Noda2024,
author = {Noda, Yoshifumi and Pisuchpen, Nisanard and Parakh, Anushri and Srinivas-Rao, Shravya and Kinowaki, Yuko and Mino-Kenudson, Mari and Kambadakone, Avinash R},
title = {Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?},
journal = {British Journal of Radiology},
year = {2024},
volume = {97},
number = {1155},
pages = {607--613},
doi = {10.1093/bjr/tqae001}
}
EUVIMED